Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jantien W. Wieringa, Gertjan J. Driessen & C. Janneke Van Der Woude. (2018) Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system. Expert Review of Gastroenterology & Hepatology 12:8, pages 811-818.
Read now
Read now
Mette Julsgaard, Mette Nørgaard, Christian Lodberg Hvas, Anne Grosen, Sara Hasseriis & Lisbet Ambrosius Christensen. (2014) Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease. Scandinavian Journal of Gastroenterology 49:3, pages 302-308.
Read now
Read now
Articles from other publishers (54)
Mathilde Barrau, Xavier Roblin, Leslie Andromaque, Aurore Rozieres, Mathias Faure, Stéphane Paul & Stéphane Nancey. (2023) What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?. Journal of Clinical Medicine 12:23, pages 7495.
Crossref
Crossref
Jiarui Chen, Rongfang Lin, Guimu Guo, Wanhong Wu, Meng Ke, Chengjie Ke, Pinfang Huang & Cuihong Lin. (2023) Physiologically‐Based Pharmacokinetic Modeling of Anti‐Tumor Necrosis Factor Agents for Inflammatory Bowel Disease Patients to Predict the Withdrawal Time in Pregnancy and Vaccine Time in Infants. Clinical Pharmacology & Therapeutics 114:6, pages 1254-1263.
Crossref
Crossref
Marwyn Sowden, Evette van Niekerk, Andre Nyandwe Hamama Bulabula & Mirjam Maria van Weissenbruch. (2023) A Narrative Review of the Tale of the Dysbiotic Microbiome in the Preterm Neonate. Dietetics 2:4, pages 308-320.
Crossref
Crossref
Mark D Russell, Mrinalini Dey, Julia Flint, Philippa Davie, Alexander Allen, Amy Crossley, Margreta Frishman, Mary Gayed, Kenneth Hodson, Munther Khamashta, Louise Moore, Sonia Panchal, Madeleine Piper, Clare Reid, Katherine Saxby, Karen Schreiber, Naz Senvar, Sofia Tosounidou, Maud van de Venne, Louise Warburton, David Williams, Chee-Seng Yee, Caroline Gordon, Ian Giles, Ian Giles, Ed Roddy, Kate Armon, Lauren Astell, Caroline Cotton, Alan Davidson, Sarah Fordham, Claire Jones, Christopher Joyce, Anoop Kuttikat, Zoe McLaren, Karen Merrison, Devesh Mewar, Amanda Mootoo & Emma Williams. (2023) British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology 62:4, pages e48-e88.
Crossref
Crossref
Joana Torres, María Chaparro, Mette Julsgaard, Konstantinos Katsanos, Zuzana Zelinkova, Manasi Agrawal, Sandro Ardizzone, Marjo Campmans-Kuijpers, Gabriele Dragoni, Marc Ferrante, Gionata Fiorino, Emma Flanagan, Catarina Frias Gomes, Ailsa Hart, Charlotte Rose Hedin, Pascal Juillerat, Annemarie Mulders, Pär Myrelid, Aoibhlinn O’Toole, Pauline Rivière, Michael Scharl, Christian Philipp Selinger, Elena Sonnenberg, Murat Toruner, Jantien Wieringa & C Janneke Van der Woude. (2023) European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation. Journal of Crohn's and Colitis 17:1, pages 1-27.
Crossref
Crossref
Amandine Dernoncourt, Sophie Liabeuf, Youssef Bennis, Kamel Masmoudi, Sandra Bodeau, Solène Laville, Anne-Sophie Hurtel-Lemaire, Valérie Gras-Champel & Benjamin Batteux. (2022) Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase®). BioDrugs 37:1, pages 73-87.
Crossref
Crossref
Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Klvana, Pavel Kohout, Vaclav Leksa, Petra Minarikova, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas & Dana Duricova. (2022) Safety of Ustekinumab and Vedolizumab During Pregnancy—Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study. Journal of Crohn's and Colitis 16:12, pages 1808-1815.
Crossref
Crossref
Laura J. O'Byrne, Safi G. Alqatari, Gillian M. Maher, Aoife M. O'Sullivan, Ali S. Khashan, Grainne P. Murphy & Fergus P. McCarthy. (2022) Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 129:8, pages 1236-1246.
Crossref
Crossref
Thomas K. Wiersma, Marijn C. Visschedijk, Nanne K. de Boer, Marjolijn N. Lub-de Hooge, Jelmer R. Prins, Daan J. Touw & Paola Mian. (2022) The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review. Pharmaceutics 14:6, pages 1241.
Crossref
Crossref
Kenneth D. Allen, Miranda K. Kiefer, Madalina Butnariu & Anita Afzali. (2022) Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare. Archives of Gynecology and Obstetrics 306:6, pages 1929-1937.
Crossref
Crossref
Kara M. De Felice & Sunanda Kane. (2021) Safety of anti-TNF agents in pregnancy. Journal of Allergy and Clinical Immunology 148:3, pages 661-667.
Crossref
Crossref
Liana Barenbrug, Maarten te Groen, Frank Hoentjen, Joris van Drongelen, Juul M.P.A. van den Reek, Irma Joosten, Elke M.G.J. de Jong & Renate G. van der Molen. (2021) Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis. Journal of Autoimmunity 122, pages 102676.
Crossref
Crossref
Christian P Selinger, Catherine Nelson-Piercy, Aileen Fraser, Veronica Hall, Jimmy Limdi, Lyn Smith, Marie Smith, Reem Nasur, Melanie Gunn, Andrew King, Aarthi Mohan, Khasia Mulgabal, Alexandra Kent, Klaartje Bel Kok & Tracey Glanville. (2021) IBD in pregnancy: recent advances, practical management. Frontline Gastroenterology 12:3, pages 214-224.
Crossref
Crossref
Kristel K Leung, Parul Tandon, Vivek Govardhanam, Cynthia Maxwell & Vivian Huang. (2021) The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflammatory Bowel Diseases 27:4, pages 550-562.
Crossref
Crossref
Katarina Mitrova, Barbora Pipek, Martin Bortlik, Ludek Bouchner, Jan Brezina, Tomas Douda, Tomas Drasar, Pavel Drastich, Premysl Falt, Pavel Klvana, Vaclav Leksa, Ales Novotny, Pavel Svoboda, Jan Skorpik, Jan Ulbrych, Marek Veinfurt, Blanka Zborilova, Milan Lukas & Dana Duricova. (2021) Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study. Therapeutic Advances in Gastroenterology 14, pages 175628482110327.
Crossref
Crossref
Barbora Pipek. (2020) Monoclonal antibodies in pregnant women with inflammatory bowel disease. Klinická farmakologie a farmacie 34:2, pages 74-77.
Crossref
Crossref
Parul Tandon, Vivek Govardhanam, Kristel Leung, Cynthia Maxwell & Vivian Huang. (2020) Systematic review with meta‐analysis: risk of adverse pregnancy‐related outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 51:3, pages 320-333.
Crossref
Crossref
J.W. Wieringa & C.J. van der Woude. (2020) Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 44-45, pages 101665.
Crossref
Crossref
Eun-Jung ParkHyungjin KimSeung Min JungYoon-Kyoung SungHan Joo Baek & Jisoo Lee. (2020) The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus. Journal of Rheumatic Diseases 27:1, pages 4.
Crossref
Crossref
Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek & Jisoo Lee. (2020) The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus. The Korean Journal of Internal Medicine 35:1, pages 41-59.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
Sunanda Kane. (2018) Trick or TREAT? More Safety Data of Infliximab During Pregnancy. American Journal of Gastroenterology 113:11, pages 1592-1593.
Crossref
Crossref
Maxime Luu, Eric Benzenine, Muriel Doret, Christophe Michiels, Alan Barkun, Thibault Degand, Catherine Quantin & Marc Bardou. (2018) Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION). American Journal of Gastroenterology 113:11, pages 1669-1677.
Crossref
Crossref
Elen Farinelli de Campos Silva, Júlio Pinheiro Baima, Jaqueline Ribeiro de Barros, Fernanda Lofiego Renosto, Carina de Fatima de Sibia, Rogério Saad-Hossne & Ligia Yukie Sassaki. (2018) Anti-TNF Exposure during Pregnancy in Crohn’s Disease Patients. Case Reports in Gastroenterology 12:3, pages 608-616.
Crossref
Crossref
Heidi Kammerlander, Jan Nielsen, Jens Kjeldsen, Torben Knudsen, Kim Oren Gradel, Sonia Friedman & Bente Mertz Nørgård. (2018) Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24:4, pages 839-848.
Crossref
Crossref
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita & Amelia Ruffatti. (2018) Devenir de la grossesse et de l’enfant après traitement par anti-TNF alpha : étude prospective multicentrique. Revue du Rhumatisme 85:1, pages 49-53.
Crossref
Crossref
Jill K. J. Gaidos & Sunanda V. Kane. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics
81
99
.
Begoña Gonzalez-Suarez, Shreyashee Sengupta & Alan C Moss. (2017) Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis. World Journal of Gastroenterology 23:45, pages 8082-8089.
Crossref
Crossref
Heidi Kammerlander, Jan Nielsen, Jens Kjeldsen, Torben Knudsen, Sonia Friedman & Bente Nørgård. (2017) The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. Inflammatory Bowel Diseases 23:6, pages 1011-1018.
Crossref
Crossref
Sumona Saha. (2017) Medication Management in the Pregnant IBD Patient. American Journal of Gastroenterology 112:5, pages 667-669.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia & C. Zaltman. (2017) Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Revista de Gastroenterología de México (English Edition) 82:2, pages 134-155.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia & C. Zaltman. (2017) Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte). Revista de Gastroenterología de México 82:2, pages 134-155.
Crossref
Crossref
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa & Angelo Viscido. (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 49:4, pages 338-358.
Crossref
Crossref
Ariela Hoxha, Antonia Calligaro, Emma Di Poi, Susanna Peccatori, Maria Favaro, Teresa Del Ross, Roberta Ramonda, Chiara Grava, Bernd Raffeiner, Paola Ravagni, Salvatore De Vita & Amelia Ruffatti. (2017) Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study. Joint Bone Spine 84:2, pages 169-173.
Crossref
Crossref
Mona Akbari & Jacqueline L. Wolf. 2017. Medical Problems During Pregnancy. Medical Problems During Pregnancy
1
32
.
Jan-Michael A. Klapproth & Gary R. Lichtenstein. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
357
365
.
Zaid Shihab, Neville D. Yeomans & Peter De Cruz. (2016) Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis. Journal of Crohn's and Colitis 10:8, pages 979-988.
Crossref
Crossref
Carina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, Rebecca Fischer-Betz, Elisabeth Elefant, Christina Chambers, Josè da Silva, Catherine Nelson-Piercy, Irene Cetin, Nathalie Costedoat-Chalumeau, Radboud Dolhain, Frauke Förger, Munther Khamashta, Guillermo Ruiz-Irastorza, Angela Zink, Jiri Vencovsky, Maurizio Cutolo, Nele Caeyers, Claudia Zumbühl & Monika Østensen. (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the Rheumatic Diseases 75:5, pages 795-810.
Crossref
Crossref
Philip Hendy, Ailsa Hart & Peter Irving. (2016) Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guide. Frontline Gastroenterology 7:2, pages 122-128.
Crossref
Crossref
Rachel Winter, Bente M. Nørgård & Sonia Friedman. (2016) Treatment of the Pregnant Patient with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 22:3, pages 733-744.
Crossref
Crossref
Geoffrey C. Nguyen, Cynthia H. Seow, Cynthia Maxwell, Vivian Huang, Yvette Leung, Jennifer Jones, Grigorios I. Leontiadis, Frances Tse, Uma Mahadevan, C. Janneke van der Woude, Alain Bitton, Brian Bressler, Sharyle Fowler, John K. Marshall, Carrie Palatnick, Anna Pupco, Joel Ray, Laura Targownik, Janneke van der Woude & William Paterson. (2016) The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 150:3, pages 734-757.e1.
Crossref
Crossref
Vivian Wai-Mei Huang, Hsiu-Ju Chang, Karen Ivy Kroeker, Karen Jean Goodman, Kathleen M. Hegadoren, Levinus Albert Dieleman & Richard Neil Fedorak. (2016) Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education. Canadian Journal of Gastroenterology and Hepatology 2016, pages 1-13.
Crossref
Crossref
Ryan A. McConnell & Uma Mahadevan. (2016) Use of Immunomodulators and Biologics Before, During, and After Pregnancy. Inflammatory Bowel Diseases 22:1, pages 213-223.
Crossref
Crossref
S Mozaffari, AH Abdolghaffari, S Nikfar & M Abdollahi. (2014) Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs. Human & Experimental Toxicology 34:5, pages 445-459.
Crossref
Crossref
Philip Hendy, Georgina Chadwick & Ailsa Hart. (2015) Republished curriculum based clinical review: IBD: reproductive health, pregnancy and lactation. Postgraduate Medical Journal 91:1074, pages 230-235.
Crossref
Crossref
C.J. van der Woude, S. Ardizzone, M.B. Bengtson, G. Fiorino, G. Fraser, K. Katsanos, S. Kolacek, P. Juillerat, A.G.M.G.J. Mulders, N. Pedersen, C. Selinger, S. Sebastian, A. Sturm, Z. Zelinkova & F. Magro. (2015) The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 9:2, pages 107-124.
Crossref
Crossref
Yesim Garip. (2015) Use of biologic agents for rheumatic diseases in pregnancy. World Journal of Rheumatology 5:2, pages 50.
Crossref
Crossref
Philip Hendy, Georgina Chadwick & Ailsa Hart. (2015) IBD: reproductive health, pregnancy and lactation. Frontline Gastroenterology 6:1, pages 38-43.
Crossref
Crossref
Corinna Weber-Schöndorfer. 2015. Drugs During Pregnancy and Lactation. Drugs During Pregnancy and Lactation
341
372
.
Neeraj Narula, Raed Al-Dabbagh, Amit Dhillon, Bruce E. Sands & John K. Marshall. (2014) Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:10, pages 1862-1869.
Crossref
Crossref
Sara Horst & Sunanda Kane. (2014) The Use of Biologic Agents in Pregnancy and Breastfeeding. Gastroenterology Clinics of North America 43:3, pages 495-508.
Crossref
Crossref
B. Pariente & D. Laharie. (2014) Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics 40:4, pages 338-353.
Crossref
Crossref
Benjamin Hassid & Uma Mahadevan. (2014) The use of biologic therapy in pregnancy. Current Opinion in Rheumatology 26:3, pages 347-353.
Crossref
Crossref
Martin Bortlik, Dana Duricova, Nadezda Machkova, Jana Kozeluhova, Pavel Kohout, Ludek Hrdlicka, Marianna Durilova, Katarina Mitrova, Ondrej Hradsky, Jiri Bronsky, Karin Malickova & Milan Lukas. (2014) Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children. Inflammatory Bowel Diseases 20:3, pages 495-501.
Crossref
Crossref